- Home
- GRDN vs BCRX Comparison
GRDN vs BCRX Comparison
Compare GRDN & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRDN
- BCRX
- Stock Information
- Founded
- GRDN 2004
- BCRX 1986
- Country
- GRDN United States
- BCRX United States
- Employees
- GRDN N/A
- BCRX N/A
- Industry
- GRDN Retail-Drug Stores and Proprietary Stores
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GRDN Consumer Staples
- BCRX Health Care
- Exchange
- GRDN Nasdaq
- BCRX Nasdaq
- Market Cap
- GRDN 1.6B
- BCRX 1.7B
- IPO Year
- GRDN 2024
- BCRX 1994
- Fundamental
- Price
- GRDN $22.53
- BCRX $10.78
- Analyst Decision
- GRDN Strong Buy
- BCRX Buy
- Analyst Count
- GRDN 2
- BCRX 8
- Target Price
- GRDN $24.50
- BCRX $16.75
- AVG Volume (30 Days)
- GRDN 227.8K
- BCRX 7.0M
- Earning Date
- GRDN 05-12-2025
- BCRX 05-05-2025
- Dividend Yield
- GRDN N/A
- BCRX N/A
- EPS Growth
- GRDN N/A
- BCRX N/A
- EPS
- GRDN N/A
- BCRX N/A
- Revenue
- GRDN $1,282,307,000.00
- BCRX $503,485,000.00
- Revenue This Year
- GRDN $11.69
- BCRX $36.61
- Revenue Next Year
- GRDN $2.55
- BCRX $13.19
- P/E Ratio
- GRDN N/A
- BCRX N/A
- Revenue Growth
- GRDN 19.55
- BCRX 41.67
- 52 Week Low
- GRDN $14.16
- BCRX $5.92
- 52 Week High
- GRDN $26.91
- BCRX $11.11
- Technical
- Relative Strength Index (RSI)
- GRDN N/A
- BCRX 66.03
- Support Level
- GRDN N/A
- BCRX $9.95
- Resistance Level
- GRDN N/A
- BCRX $10.45
- Average True Range (ATR)
- GRDN 0.00
- BCRX 0.44
- MACD
- GRDN 0.00
- BCRX -0.02
- Stochastic Oscillator
- GRDN 0.00
- BCRX 66.27
About GRDN Guardian Pharmacy Services Inc. Class A Common Stock
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.